Melanoma News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Obesity Linked to Improved Outcomes in Men With Metastatic Melanoma - OncLive



OncLive
 
Obesity Linked to Improved Outcomes in Men With Metastatic Melanoma 
OncLive
Obese men treated with targeted or immune therapies for metastatic melanoma had a 47% reduced risk of death compared with men who had a normal BMI, according to results from a retrospective multicohort analysis published in The Lancet Oncology.1. In ...

and more » 


Obesity Tied to Survival in Men With Melanoma - New York Times



New York Times
 
Obesity Tied to Survival in Men With Melanoma 
New York Times
Obese men treated for metastatic melanoma may survive longer than their normal-weight peers. Researchers did a retrospective analysis of 1,918 people, 1,155 of them men, under treatment for metastatic melanoma. The study is in Lancet Oncology. Compared ...
Obese Males May Have Melanoma Survival Advantage Genetic Engineering & Biotechnology News

all 4 news articles » 


ctDNA Can Flag Pseudoprogression in Melanoma Treated With Immunotherapy - Cancer Network



ctDNA Can Flag Pseudoprogression in Melanoma Treated With Immunotherapy 
Cancer Network
The study included 125 patients with stage IV melanoma and established BRAF or NRAS mutations receiving PD-1 antibodies alone or in combination with ipilimumab. The results were published in JAMA Oncology. Pseudoprogression was defined as a more than ...

and more » 


Obesity May Give Men With Melanoma a Survival Advantage - WebMD



Oncology Nurse Advisor
 
Obesity May Give Men With Melanoma a Survival Advantage 
WebMD
THURSDAY, Feb. 15, 2018 (HealthDay News) -- Obese men with advanced melanoma skin cancer seem to have a survival benefit over their slimmer peers, a new study suggests. Among men who received treatment for the potentially deadly cancer, obese patients ...
Obesity, Male Gender May Improve Survival Outcomes with Targeted and Immunotherapy in Melanoma Oncology Nurse Advisor

all 2 news articles » 


Merck's melanoma drug shows early promise for resistant cancers in PhI trial - Endpoints News



Endpoints News
 
Merck's melanoma drug shows early promise for resistant cancers in PhI trial 
Endpoints News
Early news on a Merck drug candidate has researchers hopeful that the investigational therapy could be used to fight drug resistant cancers. The data is early ? and on a very small patient group ? but researchers say the drug's performance matches ...
Investigational Drug for Melanoma Shows Promise in Early-Stage Study Technology Networks
Phase I Clinical Trial Shows Some Promise for Investigational Drug ... Newswise (press release)

all 3 news articles » 


Efficacy and Safety of Combination Pembrolizumab and Reduced-Dose Ipilimumab for Patients With Advanced ... - Medscape



Medscape
 
Efficacy and Safety of Combination Pembrolizumab and Reduced-Dose Ipilimumab for Patients With Advanced ... 
Medscape
Hello. This is Dr Jeffrey Weber, medical oncologist and deputy director of the Laura and Isaac Perlmutter Cancer Center at the NYU Langone Medical Center in New York City. Today I would like to discuss a paper by Georgina Long and colleagues, recently ...

 


Abl and Arg mediate cysteine cathepsin secretion to facilitate melanoma invasion and metastasis - Science



Abl and Arg mediate cysteine cathepsin secretion to facilitate melanoma invasion and metastasis 
Science
Melanoma cells secrete proteases called cathepsins, which degrade the extracellular matrix and facilitate cell migration and invasion. Tripathi et al. found that cathepsin secretion was promoted by the nonreceptor tyrosine kinase Abl. Activation of Abl ...

 


Melanoma Rates Up for Boomers, Down Among Young - WebMD



Melanoma Rates Up for Boomers, Down Among Young 
WebMD
MONDAY, Feb. 5, 2018 (HealthDay News) -- It looks like public health efforts to warn younger Americans about the dangers of tanning beds and sun exposure are paying off. Rates of the deadly skin cancer known as melanoma have dropped among Americans ...

 


Dermoscopic criteria identified for diagnosing melanoma in situ - Medical Xpress



Medical Xpress
 
Dermoscopic criteria identified for diagnosing melanoma in situ 
Medical Xpress
(HealthDay)?The most frequent dermoscopic criteria for melanoma in situ (MIS) are regression, atypical network, and irregular dots and/or globules, according to a study published online Feb. 21 in JAMA Dermatology.
Dermoscopic Criteria Accuracy Assessed in Diagnosing Melanoma ... Monthly Prescribing Reference

all 1 news articles » 


Contemporary Diagnosis and Management of Advanced Melanoma - AJMC.com Managed Markets Network



NEWS.com.au
 
Contemporary Diagnosis and Management of Advanced Melanoma 
AJMC.com Managed Markets Network
Skin cancer is the most common type of diagnosed cancer. Although nonmelanoma cancers (eg, basal cell and squamous cell) account for the vast majority of cases, melanoma is the most lethal.1,2 In 2017, an estimated 87,110 cases of melanoma will be ...
Melanoma: 'My pimple turned out to be cancer' - News.com.au NEWS.com.au

all 3 news articles »